Ad
Tuesday, 12 June 2018
Lilly-AstraZeneca latest to abandon Alzheimer's drug trials
(Reuters) - Eli Lilly and Co and AstraZeneca Plc said on Tuesday they would discontinue late-stage trials testing their Alzheimer's treatment, the latest among a slew of drugmakers to stop developing treatments for the memory-robbing disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment